Tabea Isabelle Hartung
Publications
- 2023
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients
Drexler, R., Schüller, U., Eckhardt, A., Filipski, K., Hartung, T. I., Harter, P. N., Divé, I., Forster, M-T., Czabanka, M., Jelgersma, C., Onken, J., Vajkoczy, P., Capper, D., Siewert, C., Sauvigny, T., Lamszus, K., Westphal, M., Dührsen, L. & Ricklefs, F. L., 14.02.2023, In: NEURO-ONCOLOGY. 25, 2, p. 315-325 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastoma
Divé, I., Weber, K. J., Hartung, T. I., Steidl, E., Wagner, M., Hattingen, E., Franz, K., Fokas, E., Ronellenfitsch, M. W., Herrlinger, U., Harter, P. N. & Steinbach, J. P., 2023, In: NEURO-ONCOL ADV. 5, 1, p. vdad131Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2021
Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance?
Blomen, C. L., Kött, J., Hartung, T. I., Torster, L. K. & Gebhardt, C., 20.12.2021, In: CANCERS. 13, 24, 6390.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Filipski, K., Scherer, M., Zeiner, K. N., Bucher, A., Kleemann, J., Jurmeister, P., Hartung, T. I., Meissner, M., Plate, K. H., Fenton, T. R., Walter, J., Tierling, S., Schilling, B., Zeiner, P. S. & Harter, P. N., 07.2021, In: J IMMUNOTHER CANCER. 9, 7, e002226.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review